Estimating willingness-to-pay for Kremezin in delaying the initiation of dialysis treatments among patients with chronic renal failure |
Lee Sun-Mi
(Department of Public Health, Yonsei University)
Mun Youn-Ok (Regional Cancer Center Branch, National Cancer Center) Cho Woo-Hyun (Department of Preventive Medicine, College of Medicine, Yonsei University) Lee Hoo-Yeon (Graduate School of Public Health, Yonsei University) Kang Hye-Young (Graduate School of Public Health, Yonsei University) |
1 | Sach TH, Whynes DK, O'Neill C, O'Donoghue GM, Archbold SM. Willingness-to-pay for pediatric cochlear implantation. Int J Pediatr Otorhinolaryngol 2004;68(1):91-99 DOI ScienceOn |
2 | Fautrel B, Clarke AE, Guillemin F, Adam V, St- Pierre Y, Panaritis T, et al. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective. J Rheumatol 2005; 32(3):434-53 |
3 | 이태진. 약물경제성 평가 현황과 제도 도입방향. 주요 외국의 '약물경제성평가 및 성과연구' 현황과 시사점에 대한 국제심포지엄. 서울:한국보건사회연구원;2003 |
4 | Thompson MS, Read JL, Liang M. Willingness-to-pay concepts for societal decisions in health. In: Kane RL, Kane RA, editors. Values and long-term care. Toronto: Lexington 1982. pp.103-25 |
5 | Thompson MS, Read JL, Liang M. Feasibility of willingness-to-pay measurement in chronic arthritis. Med Decis Making 1984;4:195-215 DOI |
6 | Yorioka N, Ito T, Masaki T, Ogata S, Asakimori Y, Tanji C, et al. Dose-dependent effect of an oral adsorbent, AST-120, in patients with early chronic renal failure. J Int Med Res 2002;30:467-475 DOI ScienceOn |
7 | 건강보험심사평가원. 혈액투석수가 정액화 방안에 대한 검토 보고서. 서울:건강보험심사평가원;2002 |
8 | 권미수, 김기환, 송영웅. 정보서비스의 가치측정방법론 연구: 조건부가치측정법을 중심으로. 서울:한국전산원;2004 |
9 | 김진철, 조성태, 윤종우, 김근호, 전노원, 김형직 등. 유지 혈액투석환자에서의 우울증 발생의 위험인자 및 우울중이 영양지표에 미치는 영향. 대한내과학회지 2002;62(1):77-82 |
10 | 민현조, 고경식, 김명식, 문성수, 박원도, 박철휘 등. 혈액투석환자의 삶의 질에 대한 연구. 대한신장학회지 1999;18;(5):714-732 |
11 | Chizuru I, Michiko K, Sanae I .Estimating the effect of oral adsorbent AST-120 on delay of the initiation of dialysis in patients with chronic renal failure. Progress in Medicine 2000;20:2047-2050 (Japanese) |
12 | Jampel RD, Parekh P, Johnson E, Robin AL, Miller RB. Preferences for eye drop characteristics among glaucoma specialists: a willingness-to-pay analysis. J Glaucoma 2005;14(2):151-6 DOI ScienceOn |
13 | Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford Medical Publications;1997a |
14 | Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Ch. 7. Cost-benefit analysis. In: Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxofrd University Press 1997b. pp.226 |
15 | Gafni A, Feder A. Willingness to pay in an equitable society: the case of the Kibbutz. Int J Soc Econ 1987;14:16-21 DOI |
16 | KIose T. The contingent valuation method in health care. Health Policy 1999; 47: 97-123 DOI ScienceOn |
17 | Luckmann J, Sorensen KC. Medical-Surgical nursing. 3rd ed. Philadelphia:W.B. Saunders Co.; 1987 |
18 | Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, et al. Role for 'uremic toxin' in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 1991;40(3):461-469 DOI ScienceOn |
19 | Naoki M, Hidetaka N, Katsutoshi K. Effect of oral adsorbent on diabetic renal failure patients with relation to level of serum bete-2-microglobulin at the time of first prescription of the drug. Kidney and Dialysis 2002;53(3):397-402 (Japanese) |
20 | O'Brien B, Novosel S, Torrance G, Streiner D. Assessing the economic value of a new antidepressant A willingness-to-pay approach. Pharmacoeconomics 1995;8:34-45 DOI ScienceOn |
21 | Simmons RG, Anderson CR, Abress LK. Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol Suppl 1990;131:7-22 |
22 | Portney PR. The contingent valuation debate: why economists should care. J Econ Perspct 1994;8(4):3-17 |
23 | Rydholm L, Pauling J. Contrasting feelings of helplessness in peritoneal and hemodialysis patients: a pilot study. ANNA J 1991;18(2):183-186 |
24 | Shoze K, Keizo K, Yoshiji Y. The effect of AST-120 on delaying initiation of dialysis therapy in end-stage renal disease. Dialysis 1992;32(5):191-130 (Japanese) |
25 | Yoshinobu T, Toshio O, Norihiro S. Effect of Kremezinon diabetic renal failure. Journal of Practical Diabetes 2003;20(6):721-725 (Japanese) |
26 | 대한신장학회 등록위원회. 우리나라 신대체 요법의 현황-인산 민병석 교수 기념 말기신부전환자 동록사업 2003. 대한신장학회지 2004;23(s2):s381-s404 |
27 | Lenert LA. Use of willingness to pay to study values for pharmacotherapies for migraine headache. Med Care 2003;41(2):299-308 DOI |
28 | Majkowicz M, Afeltowicz Z, Lichodziejewska-Niemierko M, Debska-Slizien A, Rutkowski B. Comparison of the quality of life in hemodialysed (HD) and peritoneally dialysed (CAPD) patients using the EORTC QLQ-C30 questionnaire. Int J Artif Organs 2000;23(7):423-428 DOI |
29 | Yoshida Y, Sakai T, Ise M. Effects of oral adsorbent in the rat model of chronic renal failure. Nephron 1992;62(3):305-314 DOI |
30 | Cross MJ, March LM, Lapsley HM, Tribe KL, Brnabic AJ, Courtenay BG, et al. Determinants of willingness to pay for hip and knee joint replacement surgery for osteoathritis. Rheumatology Oxford 2000;39:1242-8 DOI ScienceOn |
31 | Davis R. Recreation planning as an economic problem. Nat Resour J 1963:3:239-249 |
32 | Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsulrushi S, Tsutshi S. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxylsulfate levels in undialyzed uremic patients. Kidney Int 1997;62:23-28 |
33 | 양봉민, 김윤미, 김진현, 반덕진, 유왕근, 배은영. 의약분업의 경제성 평가. 서울:서울대학교 보건대학원;1998 |
34 | Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Ch. 7. Cost-benefit analysis. In: Methods for the economic evaluation of health care programmes. 2nd ed. Oxford:Oxford University Press; 1997c. pp.218 |
35 | Niwa T, Ise M Indoxyl sulfate, a circulating uremic toxin, stimulate the progression of glomerular sclerosis. J Lab Clin Med 1994;124(1):96-104 |
36 | Owada A, Nakao.M, Koike J, Ujiie K, Tomita K, Shiigai T. Effect of oral adsorbent AST-120 on the progression of chronic renal failure: A randomized controlled study. Kidney Int 1997;63:S188-S190 |
37 | Owada A, Shiigai T. Effects of oral adsorbent AST-120 concurrent with a low-protein diet on the progression of chronic renal failure. Am J Nephrol 1996;16:124-127 DOI |